Lung cancer and family-centered concerns.
Family
Focus groups
Lung cancer
Journal
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957
Informations de publication
Date de publication:
Feb 2020
Feb 2020
Historique:
received:
15
09
2018
accepted:
24
04
2019
pubmed:
9
5
2019
medline:
17
3
2020
entrez:
9
5
2019
Statut:
ppublish
Résumé
Genetic and environmental interactions predispose certain groups to lung cancer, including families. Families or caregiving units experience the disease interdependently. We have previously evaluated the concerns and preferences of patients in addressing the lung cancer experience and cancer risks in their families. This qualitative study evaluates the concerns and preferences of family members and caregivers of patients with lung cancer in the lung cancer experience and familial cancer risks. We held focus groups to discuss the format and timing of addressing these preferences and concerns. Qualitative data generated was analyzed using a grounded theory approach. Five focus groups totaling 19 participants were conducted. Seven themes were identified: (1) journey to lung cancer diagnosis has core dimensions for patient and family, (2) importance of communication between patients, families, and providers, (3) challenges for caregivers and family, (4) mixed perceptions of lung cancer causation among relatives, (5) discussion of cancer risk with relatives has complex dynamics, (6) impact of diagnosis on family health behaviors and screening, (7) role of genetic counseling. Family members of patients with lung cancer are interested in discussing risk factors, prevention, and diagnoses and also would like access to other supportive services do learn about and cope with some of the stresses and barriers they experience in the family lung cancer journey. The diagnosis represents a potential teachable moment with the opportunity to reduce the risk of LC development or improve early detection in LC patient's family members.
Sections du résumé
BACKGROUND
BACKGROUND
Genetic and environmental interactions predispose certain groups to lung cancer, including families. Families or caregiving units experience the disease interdependently. We have previously evaluated the concerns and preferences of patients in addressing the lung cancer experience and cancer risks in their families. This qualitative study evaluates the concerns and preferences of family members and caregivers of patients with lung cancer in the lung cancer experience and familial cancer risks.
METHODS
METHODS
We held focus groups to discuss the format and timing of addressing these preferences and concerns. Qualitative data generated was analyzed using a grounded theory approach.
RESULTS
RESULTS
Five focus groups totaling 19 participants were conducted. Seven themes were identified: (1) journey to lung cancer diagnosis has core dimensions for patient and family, (2) importance of communication between patients, families, and providers, (3) challenges for caregivers and family, (4) mixed perceptions of lung cancer causation among relatives, (5) discussion of cancer risk with relatives has complex dynamics, (6) impact of diagnosis on family health behaviors and screening, (7) role of genetic counseling.
CONCLUSIONS
CONCLUSIONS
Family members of patients with lung cancer are interested in discussing risk factors, prevention, and diagnoses and also would like access to other supportive services do learn about and cope with some of the stresses and barriers they experience in the family lung cancer journey. The diagnosis represents a potential teachable moment with the opportunity to reduce the risk of LC development or improve early detection in LC patient's family members.
Identifiants
pubmed: 31065838
doi: 10.1007/s00520-019-04839-5
pii: 10.1007/s00520-019-04839-5
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
497-505Références
PLoS One. 2017 Feb 7;12(2):e0170988
pubmed: 28170443
J Oncol Pract. 2013 Sep;9(5):e186-93
pubmed: 23943884
Lancet Oncol. 2017 Nov;18(11):1523-1531
pubmed: 29055736
J Clin Oncol. 2016 Oct 10;34(29):3554-3561
pubmed: 27573657
Indian J Cancer. 2013 Jul-Sep;50(3):233-8
pubmed: 24061464
Support Care Cancer. 2017 Mar;25(3):965-971
pubmed: 27866337
Health Promot J Austr. 2015 Aug;26(2):122-128
pubmed: 26177521
Cancer Causes Control. 2013 Jul;24(7):1339-46
pubmed: 23605220
BMC Cancer. 2017 May 19;17(1):348
pubmed: 28526000
BMJ Open. 2018 Jun 28;8(6):e021161
pubmed: 29959146
Behav Sci (Basel). 2017 Mar 02;7(1):
pubmed: 28257110
Eur J Oncol Nurs. 2010 Feb;14(1):23-8
pubmed: 19748315
Public Health Genomics. 2012;15(3-4):189-200
pubmed: 22488462
Psychooncology. 2011 Jan;20(1):44-52
pubmed: 20201115
BMC Public Health. 2017 May 25;17(1):503
pubmed: 28545429
Genes (Basel). 2017 Jan 17;8(1):
pubmed: 28106732
Oncol Nurs Forum. 2017 Mar 1;44(2):E55-E63
pubmed: 28222077
Support Care Cancer. 2018 Sep;26(9):3047-3053
pubmed: 29560503
Health Educ Res. 2010 Oct;25(5):792-802
pubmed: 20519265
J Clin Oncol. 2014 May 10;32(14):1480-501
pubmed: 24711559
J Thorac Cardiovasc Surg. 2012 Jul;144(1):25-32
pubmed: 22710038
Lung Cancer. 2017 Nov;113:140-151
pubmed: 29110842
Eur Respir Rev. 2017 Nov 15;26(146):
pubmed: 29141962
J Health Commun. 2009;14 Suppl 1:57-65
pubmed: 19449269
J Thorac Oncol. 2013 Dec;8(12):1474-83
pubmed: 24189514
Oncol Nurs Forum. 2013 Jul;40(4):337-46
pubmed: 23803267